With potency assays sounding positive, tick. With OTAT meeting...

With potency assays sounding positive, tick. With OTAT meeting soon with improved data submitted ( last time 9-1 in favour of Mesoblast ) tick. Dr Emerson Perin, with a late breaking inclusion to deliver results of new groundbreaking data from Mesoblast trials, that are yet to be published, at the biggest annual medical conference in the world being the American Heart Association conference. This will likely be timed in conjunction with the NEJM article which Dr Perin has collaborated on. I haven't mentioned the positive covid trial results, the ensuing presumed FDA approval to the mesoblast therapy to reduce back pain in the otherwise opiate driven market of such, or the new patents and positive figures that keep being announced. These figures are on real human patients in the pending position of mortality, and not on rodents that are induced into a so called replica state.If you read negative comments on this site then simply do yourself a favour and look up what a "downramper" or "shorter" does on the stock market in order to make money. Also have a look at their holding position and if they are not holders ask yourself the question..........would I waste my time being here if I didn't hold or had nothing to gain?